journal article text

Additional file 1: of Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib

Abstract

Figure S1. CXCR4 expression in HCC cell lines. (DOCX 109 kb

    Similar works

    Full text

    thumbnail-image